First published 9/30/2026, 12:06:15 AM · Last updated 9/30/2026, 12:06:30 AM

Maternal respiratory syncytial virus vaccination for infant protection: updated systematic review and meta-analysis of efficacy, effectiveness, and safety

A journal article published 2026-10-01 reports an updated systematic review and meta-analysis evaluating whether maternal RSV vaccination protects infants and assessing vaccine safety and effectiveness. The supplied excerpt lists the publisher as Elsevier BV and provides no additional study details.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The review summarizes evidence about maternal RSV vaccination and infant protection, which is relevant to public-health decision making.

Sources

Maternal respiratory syncytial virus vaccination for infant protection: updated systematic review and meta-analysis of efficacy, effectiveness, and safety

Report an issue